AbbVie AbbVie

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Promethera Biosciences.

    Client Virtual Booth

    PROMETHERA BIOSCIENCES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Promethera Biosciences
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Rue Granbonpré 11 Watson & Crick Hill Mont Saint Guibert, Wallonia 1435, BE
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.promethera.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/promethera-biosciences
    Twitter
    Twitter
    https://twitter.com/Promethera

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Promethera Plans to Form Joint Venture to Conduct Research and Develop Cell-Based and Biological Therapies to Treat Liver Diseases

    Details:

    The Joint Venture Company is vested with the exclusive right to develop, register, distribute and commercialize Promethera®'s therapeutic products (cell therapies and antibodies developed by Promethera® Group) in China and Southeast Asia.


    Lead Product(s): HepaStem

    Therapeutic Area: Hepatology (Liver, Pancreatic, Gall Bladder) Product Name: HepaStem

    Highest Development Status: Phase IIProduct Type: Cell and Gene therapy

    Partner/Sponsor/Collaborator: Aceso Life Science Holding

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement July 17, 2020

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Promethera® Announces Initiation of Phase 2b DHELIVER Study of HepaStem™ in Patients with Acute-on-Chronic Liver Failure (ACLF)

    Details:

    The trial is open for recruitment and aims to include 363 patients with ACLF at 110 study sites across 22 countries in Europe.


    Lead Product(s): HepaStem

    Therapeutic Area: Hepatology (Liver, Pancreatic, Gall Bladder) Product Name: Undisclosed

    Highest Development Status: Phase IIProduct Type: Cell and Gene therapy

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable January 08, 2020

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    inke-s-a-2024-08-12

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search